 | • レポートコード：MRC2302D010 • 出版社/出版日：Transparency Market Research / 2022年12月19日 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査レポートは、2022年に46億ドルであった世界の細胞溶解・破砕市場規模が2032年には155億ドルとなり、予測期間の間に年平均12.9％増加すると展望しています。当レポートでは、細胞溶解・破砕の世界市場を調査対象とし、エグゼクティブサマリー、市場概要、市場リスク・トレンド分析、市場の背景、主な成功要因、需要分析・予測、価値分析・予測、技術別（試薬ベース、物理的破砕）分析、製品種類別（機器、試薬・消耗品）分析、細胞種類別（哺乳類細胞、細菌細胞、酵母・藻類・菌類、植物細胞）分析、用途別（タンパク質単離、ダウンストリーム処理、細胞オルガネラ単離、核酸分離）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競合分析、仮定、調査手法などの項目をまとめました。並びに、当レポートに記載されている企業情報には、Thermo Fisher Scientific, Inc.、Merck KGaA、F. Hoffmann-La Roche Ltd.、Qiagen NV、Becton Dickinson & Company、Danaher Corp.、Bio-Rad Laboratories, Inc.、Miltenyi Biotec GmbH、Claremont BioSolutions, LLC、Microfluidics International Corp.、Parr Instrument Company、BioVision, Inc.、Covaris, Inc.、Qsonica LLCなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク・トレンド分析 ・市場の背景 ・主な成功要因 ・需要分析・予測 ・価値分析・予測 ・世界の細胞溶解・破砕市場規模：技術別 - 試薬ベースにおける市場規模 - 物理的破砕における市場規模 ・世界の細胞溶解・破砕市場規模：製品種類別 - 細胞溶解・破砕機器の市場規模 - 細胞溶解・破砕試薬・消耗品の市場規模 ・世界の細胞溶解・破砕市場規模：細胞種類別 - 哺乳類細胞における市場規模 - 細菌細胞における市場規模 - 酵母・藻類・菌類における市場規模 - 植物細胞における市場規模 ・世界の細胞溶解・破砕市場規模：用途別 - タンパク質単離における市場規模 - ダウンストリーム処理における市場規模 - 細胞オルガネラ単離における市場規模 - その他用途における市場規模 ・世界の細胞溶解・破砕市場規模：地域別 - 北米の細胞溶解・破砕市場規模 - 中南米の細胞溶解・破砕市場規模 - ヨーロッパの細胞溶解・破砕市場規模 - アジア太平洋の細胞溶解・破砕市場規模 - 中東・アフリカの細胞溶解・破砕市場規模 ・市場構造分析 ・競合分析 ・仮定 ・調査手法 |
Cell Lysis & Disruption Market – Scope of Report
TMR’s report on the global cell lysis & disruption market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cell lysis & disruption market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell lysis & disruption market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cell lysis & disruption market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell lysis & disruption market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cell lysis & disruption market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell lysis & disruption market.
The report delves into the competitive landscape of the global cell lysis & disruption market. Key players operating in the global cell lysis & disruption market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cell lysis & disruption market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cell lysis & disruption.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Cell Lysis & Disruption
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Cell Lysis & Disruption Market, by Key Countries
4.2. Cell Lysis & Disruption Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Cell Lysis & Disruption Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Cell Lysis & Disruption Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Cell Lysis & Disruption Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Cell Lysis & Disruption Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Technique
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Technique, 2017-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technique, 2022-2032
8.3.1. Reagent-Based
8.3.1.1. Detergent
8.3.1.2. Enzymatic
8.3.2. Physical Disruption
8.3.2.1. Mechanical Homogenization
8.3.2.2. Ultrasonic Homogenization
8.3.2.3. Pressure Homogenization
8.3.2.4. Temperature Treatments
8.4. Market Attractiveness Analysis By Technique
9. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2017-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2022-2032
9.3.1. Instruments
9.3.2. Reagents & Consumables
9.4. Market Attractiveness Analysis By Product Type
10. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Cell Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Cell Type, 2017-2021
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Cell Type, 2022-2032
10.3.1. Mammalian Cells
10.3.2. Bacterial Cells
10.3.3. Yeast/Algae/Fungi
10.3.4. Plant Cells
10.4. Market Attractiveness Analysis By Cell Type
11. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Application, 2017-2021
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022-2032
11.3.1. Protein Isolation
11.3.2. Downstream Processing
11.3.3. Cell organelle Isolation
11.3.4. Nucleic acid Isolation
11.4. Market Attractiveness Analysis By Application
12. Global Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. APAC
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Technique
13.4.3. By Product Type
13.4.4. By Application
13.4.5. By Cell Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Technique
13.5.3. By Product Type
13.5.4. By Application
13.5.5. By Cell Type
14. Latin America Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Technique
14.4.3. By Product Type
14.4.4. By Application
14.4.5. By Cell Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Technique
14.5.3. By Product Type
14.5.4. By Application
14.5.5. By Cell Type
15. Europe Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Spain
15.4.1.6. Netherlands
15.4.1.7. Rest of Europe
15.4.2. By Technique
15.4.3. By Product Type
15.4.4. By Application
15.4.5. By Cell Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Technique
15.5.3. By Product Type
15.5.4. By Application
15.5.5. By Cell Type
16. APAC Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of APAC
16.4.2. By Technique
16.4.3. By Product Type
16.4.4. By Application
16.4.5. By Cell Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Technique
16.5.3. By Product Type
16.5.4. By Application
16.5.5. By Cell Type
17. Middle East and Africa Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. Saudi Arabia
17.4.1.2. South Africa
17.4.1.3. UAE
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Technique
17.4.3. By Product Type
17.4.4. By Application
17.4.5. By Cell Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Technique
17.5.3. By Product Type
17.5.4. By Application
17.5.5. By Cell Type
18. Key Countries Cell Lysis & Disruption Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Cell Lysis & Disruption Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.2.2.1. By Technique
18.2.2.2. By Product Type
18.2.2.3. By Application
18.2.2.4. By Cell Type
18.3. Canada Cell Lysis & Disruption Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.3.2.1. By Technique
18.3.2.2. By Product Type
18.3.2.3. By Application
18.3.2.4. By Cell Type
18.4. Mexico Cell Lysis & Disruption Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.4.2.1. By Technique
18.4.2.2. By Product Type
18.4.2.3. By Application
18.4.2.4. By Cell Type
18.5. Brazil Cell Lysis & Disruption Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.5.2.1. By Technique
18.5.2.2. By Product Type
18.5.2.3. By Application
18.5.2.4. By Cell Type
18.6. Germany Cell Lysis & Disruption Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.6.2.1. By Technique
18.6.2.2. By Product Type
18.6.2.3. By Application
18.6.2.4. By Cell Type
18.7. France Cell Lysis & Disruption Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.7.2.1. By Technique
18.7.2.2. By Product Type
18.7.2.3. By Application
18.7.2.4. By Cell Type
18.8. Italy Cell Lysis & Disruption Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.8.2.1. By Technique
18.8.2.2. By Product Type
18.8.2.3. By Application
18.8.2.4. By Cell Type
18.9. Spain Cell Lysis & Disruption Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.9.2.1. By Technique
18.9.2.2. By Product Type
18.9.2.3. By Application
18.9.2.4. By Cell Type
18.10. UK Cell Lysis & Disruption Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.10.2.1. By Technique
18.10.2.2. By Product Type
18.10.2.3. By Application
18.10.2.4. By Cell Type
18.11. Netherlands Cell Lysis & Disruption Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.11.2.1. By Technique
18.11.2.2. By Product Type
18.11.2.3. By Application
18.11.2.4. By Cell Type
18.12. China Cell Lysis & Disruption Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.12.2.1. By Technique
18.12.2.2. By Product Type
18.12.2.3. By Application
18.12.2.4. By Cell Type
18.13. Japan Cell Lysis & Disruption Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.13.2.1. By Technique
18.13.2.2. By Product Type
18.13.2.3. By Application
18.13.2.4. By Cell Type
18.14. South Korea Cell Lysis & Disruption Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.14.2.1. By Technique
18.14.2.2. By Product Type
18.14.2.3. By Application
18.14.2.4. By Cell Type
18.15. Saudi Arabia Cell Lysis & Disruption Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.15.2.1. By Technique
18.15.2.2. By Product Type
18.15.2.3. By Application
18.15.2.4. By Cell Type
18.16. South Africa Cell Lysis & Disruption Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.16.2.1. By Technique
18.16.2.2. By Product Type
18.16.2.3. By Application
18.16.2.4. By Cell Type
18.17. UAE Cell Lysis & Disruption Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.17.2.1. By Technique
18.17.2.2. By Product Type
18.17.2.3. By Application
18.17.2.4. By Cell Type
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Thermo Fisher Scientific, Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Merck KGaA
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. F. Hoffmann-La Roche Ltd.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Qiagen NV
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Becton Dickinson & Company (BD)
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Danaher Corp.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Bio-Rad Laboratories, Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Miltenyi Biotec GmbH
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Claremont BioSolutions, LLC
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Microfluidics International Corp.
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.11. Parr Instrument Company
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Strategy Overview
20.3.12. BioVision, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
20.3.13. Covaris, Inc.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Strategy Overview
20.3.14. Qsonica LLC
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology